CMS Finalizes OPPS Payment for Eko Health’s SENSORA® Platform, Expanding Reimbursement for AI-Enabled Cardiac Disease Detection in Hospital-Associated Outpatient Care
Final rule establishes national reimbursement under OPPS for AI-assisted cardiac analysis, enabling earlier cardiac disease detection in routine outpatient care
SAN FRANCISCO, Dec. 2, 2025 /PRNewswire/ — Eko Health, a leader in AI-powered cardiac and pulmonary care, announced that the Centers for Medicare & Medicaid Services (CMS) has finalized national payment for its SENSORA® platform under the Outpatient Prospective Payment System (OPPS). The decision grants payment for SENSORA exams performed in outpatient settings, ensuring hospitals and health systems can receive reimbursement for AI-enabled cardiac detection delivered at the point of care.
The finalized rule establishes a national payment rate recognizing the clinical and economic value of using artificial intelligence to support the early identification of heart disease within standard outpatient workflows. This follows CMS’s July 2025 proposed rule, which first assigned SENSORA’s Category III CPT code (0962T) to APC 5734. The inclusion in the final rule reflects growing institutional support for AI tools that strengthen front-line cardiac evaluation.
